Skip to main content
. 2020 May;82(2):301–313. doi: 10.18999/nagjms.82.2.301

Table 1.

Patient characteristics

HFNC NPPV p
Patients, number 13 19
Age, year, median (range) 73 (67–76) 73 (58–77) 0.66
Male sex, number (%) 10 (77) 16 (80) 0.58
Cause of interstitial pneumonia
Idiopathic interstitial pneumonia, number 8 12
Acute exacerbation of IPF 7 11
Idiopathic NSIP 1 1
Connective tissue disease, number 4 4
Others, number 1 3
Underlying disease
Diabetes mellitus, number (%) 5 8 0.84
Chronic kidney disease, number (%) 1 0 0.41
Chronic heart disease, number (%) 1 5 0.20
Liver disease, number (%) 0 0 NA
Malignancy, number (%) 8 8 0.28
Physiological data
Tempreture, °C 37.5 (36.6–38.1) 36.8 (36.6–37.4) 0.058
Mean BP, mmHg 92 (89–98) 74 (65–94) 0.013
Respiratory rate per min 25 (20–27) 24 (21–33) 0.31
Laboratory Findings
WBC per mm3 13100 (9400–15500) 11200 (6200–16700) 0.52
CRP, mg/dL 12.2 (6.3–16.7) 12.0 (8.0–16.1) 0.80
LDH, IU/L 391 (265–498) 414(358–541) 0.51
KL-6, U/mL 682 (542–1485) 1083 (575–1398) 0.84
Arterial blood gas
PaO2, mmHg 62 (56–75) 74 (68–88) NA
PaCO2, mmHg 34 (31–36) 38 (34–40) 0.12
PaO2/FIO2 ratio 133 (105–158) 144 (114–191) 0.43
APACHE II score, median (range) 22 (18–26) 27 (25–30) 0.006
Treatment
Steroid pulse, number (%) 12 18
Steroid, number (%) 13 18
Immunosupressant, number (%) 6 6
IVCY, number (%) 1 0  

Data are presented as No. (%), or median (interquartile range) unless otherwise noted.

AE: acute exacerbation, APACHE: acute physiology and chronic health evaluation, BP: blood pressure, CRP: C-reactive protein, IPF: idiopathic pulmonary fibrosis, IVCY: intravenous cyclophosphamide, KL-6: Krebs von der Lungen-6, LDH: lactate dehydrogenase, NSIP: non-specific interstitial pneumonia, HFNC: high-flow nasal cannula, NPPV: non-invasive positive pressure ventilation.